Our 2023 publication in Nature Communications, which found that a human monoclonal antibody against Rift Valley fever virus protected mother and offspring from infection and vertical transmission, was selected as a Top-Tier Health Science paper for 2023 by the Senior Vice Chancellor’s office at Pitt Health Sciences!
Dr. Amy Hartman was invited to give a 10-minute lightning talk on our paper from 2023 titled A highly potent human neutralizing antibody prevents vertical transmission of Rift Valley fever virus in a rat model. This project was lead by Dr. Cindy McMillen, in collaboration with Drs. Nathanial Chapman (now at UNC) and James E. Crowe, Jr., at the Vanderbilt Vaccine Center.
View the original write-up on this publication here!
